Bayer Partners with Atara Therapeutics for Mesothelin-directed CAR-T Therapies
By Shikha Kashyap & Michelle Liu
Pharma Deals Review: Vol 2021 Issue 2 (Table of Contents)
Published: 4 Feb-2021
DOI: 10.3833/pdr.v2021.i2.2589 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In its latest cell and gene therapy effort, Bayer has agreed to partner with Atara Therapeutics for mesothelin-targeting chimeric antigen receptor T-cell therapies for the treatment of solid tumours...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS